Alector, a clinical-stage biotechnology company pioneering immuno-neurology, entered into a debt financing agreement with Hercules Capital for up to $50 million. Under the terms of the agreement, Alector drew an initial $10 million at closing. An...
Read Story
November 15, 2024, 08:00 AM
|
Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, has obtained a $200 million non-dilutive term loan...
Read Story
November 11, 2024, 08:08 AM
|
Arcus Biosciences, a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, obtained a $250 million term loan facility from Hercules Capital. The additional...
Read Story
August 28, 2024, 07:50 AM
|
Thumbtack, a technology company helping millions of people confidently care for and improve their homes, announced $75 million in financing from Silicon Valley Bank (SVB), a division of First Citizens Bank, and Hercules Capital. The debt facility...
Read Story
August 01, 2024, 08:00 AM
|
NeueHealth entered into a secured loan facility for up to $150 million with Hercules Capital.“This financing puts us in a strong position to advance our differentiated care model and take the lead as the industry continues to shift to value-based...
Read Story
June 24, 2024, 08:00 AM
|
Electric Hydrogen announced $100 million in corporate credit financing to support manufacturing and deployment of their innovative 100MW electrolyzer plants, which enable the lowest cost production of green hydrogen. The funding was led by HSBC, with...
Read Story
June 11, 2024, 07:52 AM
|
Electric Hydrogen announced $100 million in corporate credit financing to support manufacturing and deployment of their innovative 100MW electrolyzer plants, which enable the lowest cost production of green hydrogen. The funding was led by HSBC, with...
Read Story
May 10, 2024, 08:00 AM
|
Hercules Capital is celebrating its 20th year of originations activity by reaching the $20.0 billion milestone in total debt commitments.Founded in December 2003, and originating its first deal in 2004, the Company’s mission was simple: Provide...
Read Story
April 24, 2024, 08:00 AM
|
Sight Sciences, an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, closed an up to $65 million senior secured credit facility with Hercules Capital....
Read Story
January 24, 2024, 08:00 AM
|
Verona Pharma plc announced it and its wholly-owned subsidiary, Verona Pharma, have entered into a debt financing facility providing the Company with access to up to $400 million from funds managed by Oxford Finance and Hercules Capital. The debt...
Read Story
January 02, 2024, 07:04 AM
|
enGene Holdings, a clinical-stage genetic medicines company whose lead EG-70 program is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), entered into an amended USD $50 million loan agreement with Hercules Capital....
Read Story
December 27, 2023, 08:00 AM
|
Phathom Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced an amendment to its term loan facility from Hercules Capital. Sagard Healthcare is also...
Read Story
December 15, 2023, 07:45 AM
|
Vida Health, a leading provider of virtual cardiometabolic care services, closed $28.5 million in financing led by existing investors, including General Atlantic, Ally Bridge, Canvas Ventures, Hercules Capital, and other insiders. The Company also...
Read Story
November 13, 2023, 07:46 AM
|
Hercules Capital announced that the U.S. Small Business Administration (“SBA”) has issued a “green light” letter inviting Hercules to submit an application to obtain a license to form and operate a fourth Small Business Investment Company (“SBIC”)...
Read Story
November 10, 2023, 07:47 AM
|
Senseonics Holdings, a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, entered into a $50 million loan facility with Hercules...
Read Story
September 12, 2023, 07:45 AM
|
COMPASS Pathways plc, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, entered into a term loan agreement with Hercules Capital for up to $50 million. Kabir Nath, COMPASS Pathways Chief...
Read Story
July 05, 2023, 08:00 AM
|
Gibraltar Business Capital announced that Jim Marasco, a widely respected senior executive leader who served on GBC’s Board of Directors, is joining the GBC leadership team as Head of Originations. Prior to Gibraltar, Marasco spent over three decades...
Read Story
April 25, 2023, 07:55 AM
|
Hercules Capital announced that Hercules Adviser (“Hercules Adviser”), a wholly-owned subsidiary of Hercules Capital, has established a new institutional private credit lending program. The new private credit lending program was established to...
Read Story
March 27, 2023, 07:57 AM
|
Gibraltar Business Capital (GBC) announced the launch of its new equipment financing business, Gibraltar Equipment Finance (GEF). GEF provides term financing solutions complementing GBC’s asset based lending products and furthers GBC’s strong track...
Read Story
March 15, 2023, 08:00 AM
|
Silicon Valley Bank and Hercules Capital provided a $300 million credit facility to Oak Street Health, a network of value-based primary care centers for adults on Medicare. The financing is intended to provide Oak Street Health with operational and...
Read Story
November 17, 2022, 07:00 AM
|
Tricida entered into a debt facility with Hercules Capital. The total amount of the debt facility is $125 million of which $100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.Under the...
Read Story
October 20, 2022, 08:00 AM
|
Provention Bio, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, secured a term loan facility of up to $125 million with Hercules Capital.The term loan facility provides for up to $125 million of term...
Read Story
September 01, 2022, 07:50 AM
|
atai Life Sciences N.V., a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, announced that the company has entered into a term loan facility for up to $175 million with Hercules Capital. Under the...
Read Story
August 15, 2022, 07:52 AM
|
Gritstone bio, a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, entered into an $80 million credit facility with Hercules Capital and Silicon Valley Bank."This non-dilutive facility enhances our financial...
Read Story
July 22, 2022, 07:34 AM
|
Hercules Capital increased its existing credit facilities with MUFG Bank, Ltd. ("MUFG") and Sumitomo Mitsui Banking Corporation ("SMBC") from a combined $500.0 million to $720.0 million subject to borrowing base, leverage and other restrictions...
Read Story
June 15, 2022, 08:00 AM
|
Viridian Therapeutics, a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, entered into a debt financing agreement with Hercules Capital for up to $75 million. Under the...
Read Story
April 05, 2022, 07:40 AM
|
TG Therapeutics announced that its existing term loan facility agreement with Hercules Capital has been amended to increase the size of the facility to $200 million, with $70 million funded at closing. Michael S. Weiss, Chairman and Chief Executive...
Read Story
January 04, 2022, 07:40 AM
|
Hercules Capital announced that it, together with external funds managed by its adviser subsidiary, have originated more than a record $2.0 billion year-to-date in annual total gross debt and equity commitments, breaking its previous one-year record...
Read Story
November 29, 2021, 08:00 AM
|
Hercules Capital announced that effective November 9, 2021, it has entered into a new $100.0 million multi-currency credit facility with Sumitomo Mitsui Banking Corporation (“SMBC”).SMBC has committed a total of $100.0 million in credit capacity...
Read Story
November 10, 2021, 08:00 AM
|
Axsome Therapeutics announced that its existing term loan facility agreement with Hercules Capital has been amended to increase the size of the facility to $300 million, and the amount immediately available upon U.S. Food and Drug Administration...
Read Story
October 19, 2021, 07:49 AM
|
Corium, a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, closed on a $235 million term loan agreement with Hercules Capital. Corium will receive an initial...
Read Story
September 29, 2021, 07:32 AM
|
Better Therapeutics, a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, secured a loan facility for up to $50 million from Hercules Capital. “This transaction...
Read Story
August 26, 2021, 07:50 AM
|
Hercules Capital announced it originated more than $1.0 billion year-to-date in annual total debt and equity commitments for the fourth consecutive year."We could not be more pleased to achieve this milestone which is a testament to the strength...
Read Story
August 02, 2021, 08:00 AM
|
HiberCell completed a Series B financing round for gross proceeds of $67.4 million. Concurrent to this financing, HiberCell closed on a $30 million debt facility with Hercules Capital.The Series B round included new investors Huizenga Capital...
Read Story
May 20, 2021, 07:05 AM
|
SCYNEXIS secured a $60 million term loan facility with Hercules Capital and Silicon Valley Bank (SVB). The capital strengthens SCYNEXIS’ balance sheet ahead of the anticipated commercial launch of Brexafemme, the expected trade name for ibrexafungerp...
Read Story
May 17, 2021, 08:00 AM
|
Hercules Capital announced that Hercules Adviser LLC (“Hercules Adviser”), a wholly-owned subsidiary of Hercules Capital, has successfully closed its inaugural institutional private credit fund.“We are very pleased to announce that Hercules Adviser...
Read Story
March 25, 2021, 07:57 AM
|
AVEO Oncology announced that it has received a commitment letter for an incremental $10 million loan from Hercules Capital and its affiliates, to be added to the current tranched, $35 million debt facility secured with Hercules in August 2020 through...
Read Story
January 21, 2021, 08:00 AM
|
Udacity, which prepares employees and students for careers of the future, announced that it signed a $75 million debt facility with Hercules Capital serving as the underwriter.The company also announced that its Q3 enterprise and government bookings...
Read Story
November 05, 2020, 07:46 AM
|
Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced it has agreed to terms with Hercules Capital, Inc. on a debt facility to provide up to $80 million of new capital...
Read Story
June 09, 2020, 09:10 AM
|
Hercules Capital, Inc., the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that...
Read Story
June 08, 2020, 09:25 AM
|
Hercules Capital, Inc. the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that...
Read Story
February 20, 2020, 09:03 AM
|
Hercules Capital, Inc. announced that its board of directors has appointed Scott Bluestein as Chief Executive Officer and President, effective immediately. Mr. Bluestein, who has held several leadership roles in his nine years with the Company, has...
Read Story
July 18, 2019, 09:00 AM
|
Tricida, Inc., a pharmaceutical company focused on the development and commercialization of its drug candidate TRC101 (veverimer), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney...
Read Story
March 28, 2019, 08:55 AM
|
Hercules Capital, Inc. announced that effective immediately, Manuel Henriquez has voluntarily stepped aside as Chairman and Chief Executive Officer. The Board has elected Robert P. Badavas, currently Lead Independent Director to be Interim Chairman...
Read Story
March 13, 2019, 08:46 AM
|
Hercules Capital, Inc., the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, was named 2018 Specialty Finance...
Read Story
March 06, 2019, 08:00 AM
|
Hercules Capital, Inc., the largest and leading specialty finance provider to innovative, venture growth stage companies backed by some of the leading U.S. and top-tier venture capital and select private equity firms, today announced the appointment...
Read Story
February 22, 2019, 08:00 AM
|
Hercules Capital, Inc. announced that Hercules Capital Funding Trust 2019-1, a newly-formed wholly owned, indirect subsidiary of Hercules, has issued $250.0 million of class A notes rated A(sf) by Kroll Bond Rating Agency, Inc. (KBRA) backed by...
Read Story
January 23, 2019, 07:17 AM
|
Nabriva Therapeutics plc, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, announced the closing of up to a $75 million term loan with Hercules Capital, Inc...
Read Story
December 21, 2018, 08:00 AM
|
Hercules Capital, Inc., a specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, announced that effective May 25, 2018, it has increased its credit facility with MUFG Union Bank, N.A., under...
Read Story
June 04, 2018, 08:00 AM
|
RumbleOn, Inc., a disruptive e-commerce platform facilitating, in one online location, the ability of consumers and dealers to buy, sell, trade, and finance pre-owned vehicles with an emphasis on motorcycles and other powersports, announced it has...
Read Story
April 30, 2018, 07:05 AM
|
Mesoblast Limited announced that it has entered into a $75 million non-dilutive, four-year credit facility with Hercules Capital, Inc., a specialty finance company.
Proceeds will be primarily used towards funding the commercialization of MSC-100-IV...
Read Story
March 07, 2018, 07:00 AM
|
Hercules Capital announced that it has entered the commercial finance sector through its strategic acquisition of all of the outstanding equity of Gibraltar Business Capital (“Gibraltar”), a leading provider of working capital to small and mid-market...
Read Story
March 05, 2018, 08:00 AM
|
Motif Bio plc, a clinical stage biopharmaceutical company specializing in developing novel antibiotics, announced that the company has entered into an agreement for up to $20 million in debt financing with Hercules Capital, Inc. a provider of debt...
Read Story
November 15, 2017, 07:01 AM
|
Sorrento Therapeutics, Inc., an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, announces it has entered into a loan and security agreement with Hercules Capital, Inc. for...
Read Story
November 29, 2016, 07:23 AM
|
Hercules Capital, Inc. announced the appointment of Paul Gibson as Managing Director in the Technology Group in Hercules’ Washington DC office.“I am pleased to welcome Paul to Hercules and to have such a seasoned investment professional join our...
Read Story
September 08, 2016, 07:18 AM
|
Auris Medical Holding AG, a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, announced that it has entered into a loan facility agreement with Hercules Capital, Inc. for up to...
Read Story
July 20, 2016, 07:43 AM
|
Aprecia Pharmaceuticals Company, a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing...
Read Story
July 06, 2016, 07:46 AM
|
Plug Power Inc. has closed on a long-term loan facility for up to $40 million with Hercules Capital. The proceeds will be used for working capital and general corporate purposes. The facility has a three year term, is secured by a first priority all...
Read Story
June 28, 2016, 07:33 AM
|
FuelCell Energy, a global leader in the design, manufacture, operation and service of ultra-clean, efficient and reliable fuel cell power plants, announced that it has closed a long-term loan facility with Hercules Capital. for up to $25 million to...
Read Story
April 19, 2016, 07:39 AM
|
Hercules Capital, Inc., a specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, provided its portfolio update for Q1 2016.“I am delighted to see our organization’s...
Read Story
April 11, 2016, 07:23 AM
|
Hercules Capital, Inc., a leading specialty financing provider to innovative venture growth stage companies backed by leading venture capital firms, today announced that effective April 7, 2016, it has expanded its credit facility with Wells Fargo...
Read Story
April 08, 2016, 07:52 AM
|
Hercules Technology Growth Capital, Inc., a leading specialty financing provider to innovative venture growth, pre-IPO and M&A stage companies backed by leading venture capital firms, announced the company will change its name to Hercules Capital...
Read Story
February 22, 2016, 07:58 AM
|